Lung cancer incidence trends among men and women--United States, 2005-2009
- PMID: 24402465
- PMCID: PMC5779336
Lung cancer incidence trends among men and women--United States, 2005-2009
Erratum in
- MMWR Morb Mortal Wkly Rep. 2014 Jan 17;63(2):45
Abstract
Lung cancer is the leading cause of cancer death and the second most commonly diagnosed cancer (excluding skin cancer) among men and women in the United States. Although lung cancer can be caused by environmental exposures, most efforts to prevent lung cancer emphasize tobacco control because 80%-90% of lung cancers are attributed to cigarette smoking and secondhand smoke. One sentinel health consequence of tobacco use is lung cancer, and one way to measure the impact of tobacco control is by examining trends in lung cancer incidence rates, particularly among younger adults. Changes in lung cancer rates among younger adults likely reflect recent changes in risk exposure. To assess lung cancer incidence and trends among men and women by age group, CDC used data from the National Program of Cancer Registries (NPCR) and the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program for the period 2005-2009, the most recent data available. During the study period, lung cancer incidence decreased among men in all age groups except <35 years and decreased among women aged 35-44 years and 54-64 years. Lung cancer incidence decreased more rapidly among men than among women and more rapidly among adults aged 35-44 years than among other age groups. To further reduce lung cancer incidence in the United States, proven population-based tobacco prevention and control strategies should receive sustained attention and support.
Figures
Similar articles
-
State-specific trends in lung cancer incidence and smoking--United States, 1999-2008.MMWR Morb Mortal Wkly Rep. 2011 Sep 16;60(36):1243-7. MMWR Morb Mortal Wkly Rep. 2011. PMID: 21918494
-
Surveillance for cancers associated with tobacco use--United States, 1999-2004.MMWR Surveill Summ. 2008 Sep 5;57(8):1-33. MMWR Surveill Summ. 2008. PMID: 18772853
-
Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control.J Natl Cancer Inst. 2008 Dec 3;100(23):1672-94. doi: 10.1093/jnci/djn389. Epub 2008 Nov 25. J Natl Cancer Inst. 2008. PMID: 19033571 Free PMC article.
-
Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control.J Natl Cancer Inst. 2003 Sep 3;95(17):1276-99. doi: 10.1093/jnci/djg040. J Natl Cancer Inst. 2003. PMID: 12953083 Review.
-
Epidemiology of lung cancer.Curr Opin Pulm Med. 1998 Jul;4(4):198-204. doi: 10.1097/00063198-199807000-00002. Curr Opin Pulm Med. 1998. PMID: 10813232 Review.
Cited by
-
Endocrine toxicity of immune checkpoint inhibitors: a real-world study leveraging US Food and Drug Administration adverse events reporting system.J Immunother Cancer. 2019 Nov 6;7(1):286. doi: 10.1186/s40425-019-0754-2. J Immunother Cancer. 2019. PMID: 31694698 Free PMC article.
-
Pericardial Toxicities Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS) Database.Front Pharmacol. 2021 Jul 2;12:663088. doi: 10.3389/fphar.2021.663088. eCollection 2021. Front Pharmacol. 2021. PMID: 34276364 Free PMC article.
-
Antacid Use and De Novo Brain Metastases in Patients with Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Who Were Treated Using First-Line First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.PLoS One. 2016 Feb 19;11(2):e0149722. doi: 10.1371/journal.pone.0149722. eCollection 2016. PLoS One. 2016. PMID: 26894507 Free PMC article.
-
Race and Gender Disparities in Lung Cancer Incidence Rates, 2001-2010.J Okla State Med Assoc. 2015 Nov;108(11):482-7. J Okla State Med Assoc. 2015. PMID: 26817066 Free PMC article.
-
Panels of tumor-derived RNA markers in peripheral blood of patients with non-small cell lung cancer: their dependence on age, gender and clinical stages.Oncotarget. 2016 Aug 2;7(31):50582-50595. doi: 10.18632/oncotarget.10558. Oncotarget. 2016. PMID: 27418131 Free PMC article.
References
-
- CDC. State-specific trends in lung cancer incidence and smoking—United States, 1999–2008. MMWR. 2011;60:1243–7. - PubMed
-
- Jemal A, Cokkinides VE, Shafey O, Thun MJ. Lung cancer trends in young adults: an early indicator of progress in tobacco control (United States) Cancer Causes Control. 2003;14:579–85. - PubMed
-
- Institute of Medicine. Reducing tobacco-related cancer incidence and mortality: workshop summary. Washington, DC: The National Academies Press; 2013. Available at http://iom.edu/reports/2012/reducing-tobacco-related-cancer-incidence-an.... - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical